GlassScriptPhysician profile
Lawrence Maccree
NPI 1376527499
$48,819.15
in general payments reported to CMS, 2019-2025
13 companies · $6,444 in 2025
The $6,444 reported for 2025 was more than what 82% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $468 · 2020: $947 · 2021: $2,357 · 2022: $1,059 · 2023: $12K · 2024: $25K · 2025: $6,444.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $21K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15K · Consulting Fee: $3,750 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,250 · Food and Beverage: $2,001.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $20,987.07 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15,000.00 |
| Consulting Fee | $3,750.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,250.00 |
| Food and Beverage | $2,001.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spineology INC. | $43,807.42 | 2020-2025 | Optimesh Expandable Interbody Fusion System |
| Alphatec Spine, INC | $3,274.93 | 2021-2022 | |
| Medical Device Business Services, INC. | $720.61 | 2020 | |
| Boston Scientific Corporation | $269.65 | 2023-2025 | Wavewriter Alpha Prime 16 |
| Depuy Synthes Sales INC. | $236.27 | 2019-2020 | |
| Amgen INC. | $123.66 | 2019 | |
| Abbott Laboratories | $123.59 | 2022 | |
| Stryker Corporation | $98.60 | 2019 | |
| Si-Bone, INC. | $84.35 | 2019 | |
| Intrinsic Therapeutics | $33.77 | 2023 | Barricaid Acd (Annular Closure Device) |
| Nevro Corp. | $17.28 | 2021 | |
| Providence Medical Technology, INC. | $14.75 | 2025 | |
| Sanara Medtech INC. | $14.27 | 2023 | Celleraterx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Maccree listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.